HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Frataxin deficiency unveils cell-context dependent actions of insulin-like growth factor I on neurons.

AbstractBACKGROUND:
Friedreich's ataxia (FRDA) is a neurodegenerative disease caused by deficiency of the mitochondrial iron chaperone frataxin (Fxn). FRDA has no cure, but disease-modifying strategies to increase frataxin are under study. Because insulin-like growth factor I (IGF-I) has therapeutic effects in various types of cerebellar ataxia and exerts protective actions on mitochondrial function, we explored the potential Fxn-stimulating activity of this growth factor on brain cells.
RESULTS:
IGF-I normalized frataxin levels in frataxin-deficient neurons and astrocytes through its canonical Akt/mTOR signaling pathway. IGF-I also stimulated frataxin in normal astrocytes but not in normal neurons, whereas IGF-I stimulated the Akt/mTOR pathway in both types of cells. This cell context-dependent action of IGF-I on neurons suggested that the intrinsic regulation of Fxn in neurons is different than in astrocytes. Indeed, neurons express much higher levels of frataxin and are much more sensitive to Fxn deficiency than astrocytes; i.e.: only neurons die in the absence of frataxin. In addition, the half-life of frataxin is shorter in neurons than in astrocytes, while after blockade of the proteasome only neurons responded to IGF-I with an increase in frataxin levels. We also explore a potential therapeutic utility of IGF-I in FRDA-like transgenic mice (YG8R mice) and found that treatment with IGF-I normalized motor coordination in these moderately ataxic mice.
CONCLUSION:
Exposure to IGF-I unveiled a cell-specific regulation of frataxin in neurons as compared to astrocytes. Collectively, these results indicate that IGF-I exerts cell-context neuroprotection in frataxin deficiency that maybe therapeutically effective.
AuthorsCarolina Franco, Silvia Fernández, Ignacio Torres-Alemán
JournalMolecular neurodegeneration (Mol Neurodegener) Vol. 7 Pg. 51 (Oct 05 2012) ISSN: 1750-1326 [Electronic] England
PMID23039828 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Iron-Binding Proteins
  • frataxin
  • Insulin-Like Growth Factor I
Topics
  • Animals
  • Astrocytes (metabolism)
  • Cells, Cultured
  • Female
  • Friedreich Ataxia (metabolism)
  • Humans
  • Insulin-Like Growth Factor I (metabolism, pharmacology)
  • Iron-Binding Proteins (metabolism)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Transgenic
  • Neurons (metabolism)
  • Real-Time Polymerase Chain Reaction
  • Signal Transduction (physiology)
  • Transfection

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: